Head and Neck Cancer Archives

A trial in phase 2 metastatic prostate cancer shows that some patients likely to benefit from ipilimumab treatment, even with low number of tumor mutations.

General Oncology

Response Endpoints Deemed ‘Poor Surrogates’ for Overall Survival in Trials of Immune Checkpoint Inhibitors

By

Jonathan Goodman, MPhil

August 5, 2021

Response endpoints were not strongly correlated with overall survival at the trial level.

Head and Neck Cancer

Patient Perception of Outcomes Associated With Psychosocial Function After Reconstruction for Head and Neck Cancer

By

Vicki Moore, PhD

July 28, 2021

Survey-based study determined the association between patients’ perception of aesthetic outcome and psychosocial function after undergoing ablation with this complex procedure.

Issues in Cancer Survivorship

Taste, Smell Dysfunction May Persist After HNSCC Treatment for Longer Than Survivors Anticipate

By

Bette Weinstein Kaplan

July 19, 2021

Researchers sought to determine when and to what extent survivors of head and neck squamous cell cancers would recover their senses of taste and smell.

Head and Neck Cancer

Survey Identified Risk Factors Linked to Voice, Speech Impairment in Survivors of Oropharyngeal Cancer

By

Vicki Moore, PhD

May 19, 2021

A survey of long-term survivors of oropharyngeal cancer identified those with higher risk of experiencing voice and speech impairment.

ONS Annual Congress 2021

Managing Oral Care for Patients With Head and Neck Cancers

By

Vicki Moore, PhD

April 26, 2021

A review of the significance of oral and dental care for patients with head and neck cancer.

Head and Neck Cancer

New Dosing Regimen Approved for Erbitux in Colorectal, Head and Neck Cancer

By

Brian Park, PharmD

April 7, 2021

The new dosing schedule is in addition to the approved weekly dosage regimen.

Whether cryosurgery or cryoablation will prove a viable alternative to lumpectomy — the standard of

Head and Neck Cancer

Endoscopic Surgery Improved OS for Locally Recurrent Nasopharyngeal Cancer

By

Leah Lawrence

March 31, 2021

A team of investigators conducted a randomized controlled trial to assess outcomes following salvage endoscopic surgery vs radiation therapy in patients with resectable, locally recurrent nasopharyngeal cancer.

Head and Neck Cancer

KESTREL Trial Testing Durvalumab With or Without Tremelimumab in HNSCC Misses OS End Points

By

Andrea S. Blevins Primeau, PhD, MBA

February 23, 2021

Investigators of the phase 3 KESTREL trial recruited 823 patients with previously untreated recurrent or metastatic head and neck squamous cell carcinoma (HNSCC).

General Oncology

American Cancer Society 2021 Statistics Report Shows Continuous Decline in Cancer Mortality Rate, Illuminates Disease-Specific Trends

By

Rachel Narozniak, MA

February 4, 2021

The American Cancer Society’s annual report approximates the new cancer diagnoses and deaths expected in 2021 and identifies impactful patterns in oncology care.

Patients with anemia had worse in-hospital outcomes.

Head and Neck Cancer

Symptom Assessment Scores Associated With Unplanned Hospitalizations in Patients With Head and Neck Cancer

By

Jessica Nye, PhD

January 29, 2021

Population-based study demonstrated an association between patient-reported outcomes and ED visits/unplanned hospitalizations among patients with head and neck cancer.